HDL as a target in the treatment of atherosclerotic cardiovascular disease
P Linsel-Nitschke, AR Tall - Nature reviews Drug discovery, 2005 - nature.com
Lipid abnormalities are among the key risk factors for cardiovascular disease. Indeed, lipid-
modifying drugs—in particular, the statins, which primarily lower plasma levels of low …
modifying drugs—in particular, the statins, which primarily lower plasma levels of low …
[引用][C] HDL as a target in the treatment of atherosclerotic cardiovascular disease
P LINSEL-NITSCHKE - Nat Rev Drug Discov, 2005 - cir.nii.ac.jp
[引用][C] HDL AS TARGET IN THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
PL NITSCHKE, AR TALL - 2005 - sid.ir
HDL as a target in the treatment of atherosclerotic cardiovascular disease.
P Linsel-Nitschke, AR Tall - Nature reviews. Drug Discovery, 2005 - europepmc.org
Lipid abnormalities are among the key risk factors for cardiovascular disease. Indeed, lipid-
modifying drugs-in particular, the statins, which primarily lower plasma levels of low-density …
modifying drugs-in particular, the statins, which primarily lower plasma levels of low-density …
HDL as a target in the treatment of atherosclerotic cardiovascular disease.
P Linsel-Nitschke, AR Tall - Nature Reviews Drug Discovery, 2005 - search.ebscohost.com
Lipid abnormalities are among the key risk factors for cardiovascular disease. Indeed, lipid-
modifying drugs-in particular, the statins, which primarily lower plasma levels of low-density …
modifying drugs-in particular, the statins, which primarily lower plasma levels of low-density …
[PDF][PDF] HDL AS A TARGET IN THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
P Linsel-Nitschke, AR Tall - NATURE REVIEWS| DRUG …, 2005 - fulltext.calis.edu.cn
Lipid abnormalities are among the key risk factors for cardiovascular disease. Indeed, lipid-
modifying drugs—in particular, the statins, which primarily lower plasma levels of lowdensity …
modifying drugs—in particular, the statins, which primarily lower plasma levels of lowdensity …
HDL as a target in the treatment of atherosclerotic cardiovascular disease
P Linsel-Nitschke, AR Tall - Nature Reviews Drug Discovery, 2005 - go.gale.com
Lipid abnormalities are among the key risk factors for cardiovascular disease. Indeed, lipid-
modifying drugs--in particular, the statins, which primarily lower plasma levels of low-density …
modifying drugs--in particular, the statins, which primarily lower plasma levels of low-density …
HDL as a target in the treatment of atherosclerotic cardiovascular disease
P Linsel-Nitschke, AR Tall - Nature reviews. Drug …, 2005 - pubmed.ncbi.nlm.nih.gov
Lipid abnormalities are among the key risk factors for cardiovascular disease. Indeed, lipid-
modifying drugs-in particular, the statins, which primarily lower plasma levels of low-density …
modifying drugs-in particular, the statins, which primarily lower plasma levels of low-density …
[引用][C] Correction: HDL as a target in the treatment of atherosclerotic cardiovascular disease
P Linsel-Nitschke, AR Tall - Nature Reviews Drug Discovery, 2005 - nature.com
[引用][C] HDL as a target in the treatment of atherosclerotic cardiovascular disease
P Linsel-Nitschke, AR Tall - Nature Reviews Drug Discovery, 2005 - go.gale.com